On 26 October 2024, the Working Conference of the In Vitro Diagnostics Industrial Development Institute (IIDI), part of the Shanghai Academy of Experimental Medicine (SAEM), took place in Hangzhou.
On 25-26 October, 2024, China Association of In-Vitro Diagnostics, National Association Health Industry Enterprise Management, held its expanded working meeting in Hangzhou, China, focusing on strategic developments in the in-vitro diagnostics (IVD) sector.
From 16 to 18 March 2024, the bustling halls of Chongqing International Expo Center witnessed a remarkable convergence of innovations and advancements, as the 21st China International In Vitro Diagnostic Expo and the 4th China IVD Supply Chain Expo concluded with resounding success.
The 4th China Key Raw Material & Parts Forum (CKRMPF) is scheduled to be held at Chongqing Yuelai International Conventional Center on 15 March in 2024.
The 9th China Experimental Medicine Conference (CEMC) will be held grandly from March 15-16, 2024 at Chongqing Yuelai International Conference Center. *Simultaneous interpretation (CNH/EN) is provided onsite.
China Association of In Vitro Diagnostics (CAIVD) and In Vitro Diagnostics Society of China Association for Medical Devices Industry jointly compiled this report.
On May 27, 2023, the 8th China Experimental Medicine Conference was held successfully at Primus Hotel Nanchang International Expo City.
The 10th China IVD Industry Development Conference (CIIDC) is scheduled to be held at Primus Hotel Nanchang International Expo City from May 28 to 29 in 2023.
✔ All (8)
✔ Press release (7)
✔ Industry news (1)
Don’t miss important updates about the show and the in vitro diagnostic industry.
Sign-up for our newsletter today.
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.